[Long-term local tolerability to intranasally administered salmon calcitonin in post-menopausal osteoporosis]. 1992

L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
Istituto Policattedra di Clinica Otorinolaringoiatrica, Università degli Studi di Parma.

The aim of this study was to acquire further knowledge relative to the local tolerability of synthetic salmon Calcitonin, administered by the intranasal route. The Authors have evaluated several olfactometry parameters in a group of patients treated for twelve months with the drug. The Wright matrix test and the olfacto-respiratory reflex test were performed. An evaluation regarding mucociliary transport time was additionally effected. No interference on the part of the drug was reported regarding the functional parameters of the nasal mucosa. The excellent local tolerability of intranasal salmon Calcitonin, as already indicated by other Authors, was confirmed, even in terms of specific parameters relative to the olfactory functions.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009831 Olfactory Mucosa That portion of the nasal mucosa containing the sensory nerve endings for SMELL, located at the dome of each NASAL CAVITY. The yellow-brownish olfactory epithelium consists of OLFACTORY RECEPTOR NEURONS; brush cells; STEM CELLS; and the associated olfactory glands. Olfactory Epithelium,Olfactory Membrane,Epithelium, Olfactory,Membrane, Olfactory,Membranes, Olfactory,Mucosa, Olfactory,Olfactory Membranes
D012018 Reflex An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D012903 Smell The ability to detect scents or odors, such as the function of OLFACTORY RECEPTOR NEURONS. Olfaction,Sense of Smell,Smell Sense
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015663 Osteoporosis, Postmenopausal Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency. Bone Loss, Perimenopausal,Bone Loss, Postmenopausal,Perimenopausal Bone Loss,Postmenopausal Bone Loss,Postmenopausal Osteoporosis,Osteoporosis, Post-Menopausal,Bone Losses, Perimenopausal,Bone Losses, Postmenopausal,Osteoporoses, Post-Menopausal,Osteoporoses, Postmenopausal,Osteoporosis, Post Menopausal,Perimenopausal Bone Losses,Post-Menopausal Osteoporoses,Post-Menopausal Osteoporosis,Postmenopausal Bone Losses,Postmenopausal Osteoporoses

Related Publications

L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
September 1980, Minerva medica,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
January 1989, Minerva endocrinologica,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
January 1986, Revue medicale de Liege,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
January 1991, Minerva medica,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
October 1987, La Clinica terapeutica,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
January 1991, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
May 1982, Minerva medica,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
January 1976, Postgraduate medical journal,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
January 1997, Clinical endocrinology,
L M Gariboldi, and I Bolla, and M C Baroni, and R Delsignore, and M Passeri, and F Barberis
December 1994, Aging (Milan, Italy),
Copied contents to your clipboard!